Dexcel Pharma Technologies Ltd. 3
3 · Intec Pharma Ltd. · Filed Feb 14, 2019
Insider Transaction Report
Form 3
Dexcel Pharma Technologies Ltd.
10% Owner
Holdings
- 5,150,848
Ordinary Shares
Footnotes (1)
- [F1]Dexcel Pharma Technologies Ltd. ("DPT") and DPT's President and Chief Executive Officer, Dan Oren, are filing this Form 3 because they may be deemed to have beneficial ownership over 5,150,848 ordinary shares (the "Common Shares") of Intec Pharma Ltd. (the "Issuer"). The Common Shares are directly owned by DPT. Mr. Oren is ultimately the sole shareholder of DPT.